NCT00062179 - Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions

Lung Cancer

Interventions

DRUG

carboplatin

Carboplatin: dosed at an AUC of 6 by the Calvert Formula 3 cycles of carboplatin 21 days apart

DRUG

celecoxib

Celecoxib: 400 mg po BID celecoxib 3-7 days before first dose of chemotherapy

DRUG

paclitaxel

Paclitaxel: 225 mg/m2 by 3-hour intravenous infusion 3 cycles of paclitaxel 21 days apart

OTHER

Placebo

placebo 3-7 days before first dose of chemotherapy

Trial Locations (2)

New York Weill Cornell Cancer Center at Cornell University, New York

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles